These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11207233)

  • 41. [Neonatal withdrawal syndrome to selective serotonin reuptake inhibitors: case report and literature review].
    Agut-Quijano T; Martínez-Nadal S; Elizari-Saco MJ; Sala-Castellví P; Vila-Cerén C; Raspall-Torrent F
    Rev Neurol; 2006 Jun 1-15; 42(11):660-2. PubMed ID: 16736401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolonged neonatal complications after in utero exposure to fluoxetine.
    Alehan F; Saygi S; Tarcan A; Gürakan B
    J Matern Fetal Neonatal Med; 2008 Dec; 21(12):921-3. PubMed ID: 18985556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Judge might reopen GSK paroxetine case.
    Dyer C
    BMJ; 2016 Feb; 352():i800. PubMed ID: 26858261
    [No Abstract]   [Full Text] [Related]  

  • 44. Lawyers may seek judicial review of panel reviewing paroxetine.
    Dobson R
    BMJ; 2003 Mar; 326(7390):618. PubMed ID: 12649225
    [No Abstract]   [Full Text] [Related]  

  • 45. Spontaneous ecchymoses due to paroxetine administration.
    Cooper TA; Valcour VG; Gibbons RB; O'Brien-Falls K
    Am J Med; 1998 Feb; 104(2):197-8. PubMed ID: 9528740
    [No Abstract]   [Full Text] [Related]  

  • 46. Galactorrhea after paroxetine treatment.
    González E; Minguez L; Sanguino RM
    Pharmacopsychiatry; 2000 May; 33(3):118. PubMed ID: 10855465
    [No Abstract]   [Full Text] [Related]  

  • 47. Discontinuation syndrome following late pregnancy exposure to antidepressants.
    Koren G
    Arch Pediatr Adolesc Med; 2004 Apr; 158(4):307-8. PubMed ID: 15066865
    [No Abstract]   [Full Text] [Related]  

  • 48. The serotonin syndrome complicating co-prescription of paroxetine and clarithromycin.
    Jaber BL; Lobon LF; Madias NE
    Am J Med; 2006 Apr; 119(4):e3. PubMed ID: 16564762
    [No Abstract]   [Full Text] [Related]  

  • 49. Serotonin syndrome following the administration of tramadol with paroxetine.
    Lantz MS; Buchalter EN; Giambanco V
    Int J Geriatr Psychiatry; 1998 May; 13(5):343-5. PubMed ID: 9658268
    [No Abstract]   [Full Text] [Related]  

  • 50. Neonatal encephalopathy after antidepressant exposure during pregnancy. Herbst F, Gortner L. Paroxetine withdrawal syndrome as differential diagnosis of acute neonatal encephalophathy? Z Geburtsh Neonatol 2003; 207: 232-234.
    Jessel N; Stiskal JA
    Z Geburtshilfe Neonatol; 2004 Apr; 208(2):75-6; author reply 76. PubMed ID: 15112141
    [No Abstract]   [Full Text] [Related]  

  • 51. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
    Gentile S; Bellantuono C
    J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can venlafaxine in breast milk attenuate the norepinephrine and serotonin reuptake neonatal withdrawal syndrome.
    Koren G; Moretti M; Kapur B
    J Obstet Gynaecol Can; 2006 Apr; 28(4):299-301. PubMed ID: 16776907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Restoring Study 329: Paroxetine neither effective nor safe for adolescents.
    Mulder R; Rucklidge JJ; Toop L
    Aust N Z J Psychiatry; 2016 Sep; 50(9):922-3. PubMed ID: 27389067
    [No Abstract]   [Full Text] [Related]  

  • 54. Paroxetine in the treatment of generalised anxiety disorder.
    Snyderman SH; Rynn MA; Bellew K; Rickels K
    Expert Opin Pharmacother; 2004 Aug; 5(8):1799-806. PubMed ID: 15264994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Increased perioperative blood loss during treatment with paroxetine].
    Sewnath ME; van Hillegersberg R; Koopman MM; Levi MM; Gouma DJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(38):1800-2. PubMed ID: 12369443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chronic cough under treatment with paroxetine].
    Hamel H; Bonniaud P; Sgro C; Foucher P; Camus P
    Presse Med; 2000 May 27-Jun 3; 29(19):1045. PubMed ID: 10874912
    [No Abstract]   [Full Text] [Related]  

  • 58. [The seroxat issue].
    Asbøll E
    Tidsskr Nor Laegeforen; 2005 Dec; 125(24):3522-3; author reply 3523. PubMed ID: 16357918
    [No Abstract]   [Full Text] [Related]  

  • 59. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
    Blier P; Bergeron R; de Montigny C
    Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Severe transient neonatal long QT syndrome due to maternal paroxetine usage: a case report.
    Leerssen ECM; Tak RO; Breur JMPJ
    Cardiol Young; 2019 Oct; 29(10):1300-1301. PubMed ID: 31475669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.